Clinical Features Associated With Fatigue in People With Fibrotic Interstitial Lung Disease: Cross‐Sectional Study
Respirology · 2025
DOI: 10.1111/resp.70091 ↗At a glance
Randomisierte kontrollierte Studie in Respirology, 2025. Written by Shohei Kawachi and 2 co-authors. Institution: Respiratory Research@Alfred, School of Translational Medicine, Monash University, Melbourne, Victoria, Australia. Major MEDLINE topics: Fatigue, Lung Diseases, Interstitial, Pulmonary Fibrosis. 47 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: National Health and Medical Council (Australia).
Abstract (original language)
Background and Objective Fatigue significantly impacts quality of life in fibrosing interstitial lung diseases (fILDs). Oxyhaemoglobin desaturation contributes to fatigue in chronic obstructive pulmonary disease; however, this has not been investigated in fILD. This study aimed to elucidate the relationship between fatigue and clinical features, including oxyhaemoglobin desaturation, in fILD.
Methods
Participants had stable fILD with exertional desaturation (SpO 2 ≤ 88% on 6‐min walk test, 6MWT). Univariate and multivariate analyses were performed with fatigue as the dependent variable and the clinical features related to fatigue as independent variables. Fatigue was assessed using the Fatigue Severity Scale (FSS). Independent variables were specified a priori using directed acyclic graphs based on previous studies: age, BMI, severity (FVC%), Dyspnoea‐12 score, physical activity (mean daily steps), desaturation (nadir SpO 2 during 6MWT and during daily life), presence of corticosteroids, and obstructive sleep apnoea.
Results
One hundred and sixteen participants were included with mean (SD) age of 70.9 (9.8), FVC% of 69.8 (16.1). Seventy‐two participants (62%) had substantial fatigue (≥ 36 on FSS). Univariate analysis showed no relationship between FSS and nadir SpO 2 during 6MWT ( r = −0.03, p = 0.76) or minimum SpO 2 during daily life ( r = 0.04, p = 0.74). Multiple regression analyses showed associations between higher fatigue on FSS and greater breathlessness on Dyspnoea‐12 (standardised beta = 0.546, p < 0.001) and lower daily steps (standardised beta = −0.188, p = 0.02).
Conclusion
Dyspnoea and physical activity are associated with fatigue in fILD. Exertional desaturation does not appear to contribute to fatigue in this group. Trial Registration ClinicalTrials.gov Registry (URL: https://clinicaltrials.gov/study/NCT03737409 )
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Respiratory Research@Alfred, School of Translational Medicine, Monash University, Melbourne, Victoria, Australia.
- Department of Rehabilitation, Shinshu University Hospital, Matsumoto, Japan.
- Institute for Breathing and Sleep, Melbourne, Victoria, Australia.
- Department of Physiotherapy and Respiratory Medicine, Alfred Health, Melbourne, Victoria, Australia.
ORCID profiles: Shohei Kawachi, Anne E Holland
Funding
- National Health and Medical Council (Australia)
Cite
APA
Kawachi, S., Hoffman, M., & Holland, A. E. (2025). Clinical Features Associated With Fatigue in People With Fibrotic Interstitial Lung Disease: Cross‐Sectional Study. Respirology. https://doi.org/10.1111/resp.70091
Vancouver
Kawachi S, Hoffman M, Holland AE. Clinical Features Associated With Fatigue in People With Fibrotic Interstitial Lung Disease: Cross‐Sectional Study. Respirology. 2025. doi:10.1111/resp.70091
BibTeX
@article{Kawachi2025,
author = {Kawachi, Shohei and Hoffman, Mariana and Holland, Anne E},
title = {Clinical Features Associated With Fatigue in People With Fibrotic Interstitial Lung Disease: Cross‐Sectional Study},
journal = {Respirology},
year = {2025},
doi = {10.1111/resp.70091}
}
EUVIMED